Gilead Sciences
GILD
GILD
1,502 hedge funds and large institutions have $81.5B invested in Gilead Sciences in 2017 Q3 according to their latest regulatory filings, with 123 funds opening new positions, 601 increasing their positions, 613 reducing their positions, and 122 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 1,516 → 1,502 (-14)
2% less repeat investments, than reductions
Existing positions increased: 601 | Existing positions reduced: 613
28% less call options, than puts
Call options by funds: $1.87B | Put options by funds: $2.61B
Holders
1,502
Holding in Top 10
96
Calls
$1.87B
Puts
$2.61B
Top Buyers
| 1 | +$758M | |
| 2 | +$398M | |
| 3 | +$374M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$357M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$274M |
Top Sellers
| 1 | -$359M | |
| 2 | -$356M | |
| 3 | -$246M | |
| 4 |
Millennium Management
New York
|
-$208M |
| 5 |
State Street
Boston,
Massachusetts
|
-$207M |